KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Treasury Shares (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Treasury Shares for 17 consecutive years, with $17.2 billion as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 1.98% to $17.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.2 billion through Dec 2025, up 1.98% year-over-year, with the annual reading at $17.2 billion for FY2025, 1.98% up from the prior year.
  • Treasury Shares hit $260.2 million in Q4 2025 for Abbott Laboratories, up from $257.9 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $260.2 million in Q4 2025 to a low of $205.4 million in Q1 2021.
  • Historically, Treasury Shares has averaged $243.1 million across 5 years, with a median of $250.1 million in 2024.
  • Biggest five-year swings in Treasury Shares: decreased 0.69% in 2021 and later soared 39.42% in 2022.
  • Year by year, Treasury Shares stood at $11.8 billion in 2021, then grew by 28.82% to $15.2 billion in 2022, then grew by 4.94% to $16.0 billion in 2023, then grew by 5.4% to $16.8 billion in 2024, then grew by 1.98% to $17.2 billion in 2025.
  • Business Quant data shows Treasury Shares for ABT at $17.2 billion in Q4 2025, $16.9 billion in Q3 2025, and $16.6 billion in Q2 2025.